English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA study from the University of Illinois Urbana-Champaign and CIATEJ in Guadalajara, Mexico, explored the composition of seed coat extracts from black and pinto bean varieties unique to the Chiapas region of Southern Mexico.
Tag: anti-inflammatory
A Mediterranean diet not only boosts health, but also improves fertility
With an emphasis on fruits, vegetables and legumes, the Mediterranean diet has long been applauded for its multiple health benefits. Now, new research shows that it may also help overcome infertility, making it a non-intrusive and affordable strategy for couples trying to conceive.
Anti-inflammatory compound shows potential in treating patients with severe COVID-19
An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.
Dendrobium Signatum and Egg Magnolia – Ultimate Extracts for Skincare. Chula Researchers Champion Thai Herbs to Revive the Thai Economy
Chula Faculty of Science has found new antioxidant and anti-inflammatory substances from Dendrobium signatum and Egg Magnolia extracts and aims to expand on its economic potential as a natural beauty product.
How Did Red Algae Survive in Extreme Environments?
Red algae have persisted in hot springs and surrounding rocks for about 1 billion years. Now, a Rutgers-led team will investigate why these single-celled extremists have thrived in harsh environments – research that could benefit environmental cleanups and the production of biofuels and other products.
Could the time of day impact the effectiveness of COVID-19 treatment?
For months, experts have warned against the use of anti-inflammatory medications, such as ibuprofen, to treat COVID-19 symptoms. But could the timing of when this drug is taken play a role in its effectiveness?
Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients
Evelo Biosciences, Inc. (Nasdaq:EVLO), Rutgers University, and Robert Wood Johnson University Hospital today announced the submission of an Investigational New Drug (IND) application for an Evelo-sponsored Phase 2 clinical study evaluating the safety and efficacy of EDP1815 for the treatment of hospitalized patients with newly diagnosed COVID-19. The study will be led by Reynold A. Panettieri, Jr., M.D., Vice Chancellor for Translational Medicine and Science at Rutgers Biomedical and Health Sciences and Professor of Medicine at Rutgers Robert Wood Johnson Medical School.
COVID-19 and the Challenging Acute Respiratory Distress Syndrome (ARDS)
Joe G. N. “Skip” Garcia, MD, an academic pulmonary physician-scientist describes a complication in COVID-19.